在鵬躍醫藥的產品開發中，我們積極推進鼻腔內給藥的肽類藥物研發。這種創新方法旨在通過鼻腔給藥以提升治療效果。我們的重點是開發針對腦相關疾病的靶向傳遞系統，如阿茲海默症、帕金森病和腦癌等。我們致力於革新治療方案，改善這些具有挑戰性的領域中的患者結果。

Under our product development efforts at PenTide Therapeutics, we are actively working on the advancement of intranasal peptide drugs. This innovative approach aims to utilize nasal delivery for enhanced therapeutic outcomes. Our focus lies in developing targeted delivery systems for brain-related conditions, such as Alzheimer’s disease, Parkinson’s disease, and brain cancers. We are committed to revolutionizing treatment options and improving patient outcomes in these challenging areas.